2080 K Ginger Mint

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for use in patients as determined by the prescribing healthcare professional. Currently, there are no specific indications or usage details provided.

There are no known teratogenic or nonteratogenic effects associated with this drug. Healthcare professionals should consider the absence of these effects when evaluating treatment options for their patients.

Dosage and Administration

The toothpaste contains 1,000 ppm fluoride, which is intended for use in the prevention of dental caries.

For optimal results, it is recommended that healthcare professionals advise patients to use a pea-sized amount of toothpaste. Patients should brush their teeth at least twice daily, preferably in the morning and before bedtime.

Instruct patients to apply the toothpaste to a soft-bristled toothbrush and to brush for a minimum of two minutes, ensuring that all surfaces of the teeth are adequately cleaned. After brushing, patients should avoid rinsing, eating, or drinking for at least 30 minutes to maximize fluoride retention on the teeth.

Healthcare professionals should monitor patients for any signs of excessive fluoride exposure and provide guidance on appropriate use, especially in children.

Contraindications

Use of this product is contraindicated in patients who experience irritation to the gums, teeth, or oral mucosa. In such cases, it is advised to discontinue use and consult a dentist for further evaluation and management.

Warnings and Precautions

The product is intended solely for the purposes specified on the label. It is imperative that healthcare professionals advise patients against using the product for any other applications. In the event of eye contact, immediate rinsing with water is essential. Should irritation persist following rinsing, medical assistance must be sought without delay.

To ensure safety, the product must be stored out of reach of children, particularly those under the age of six. This precaution is critical to prevent accidental ingestion or misuse.

Patients should be instructed to discontinue use of the product and consult their dentist if they experience any irritation to the gums, teeth, or oral mucosa. Monitoring for such adverse reactions is essential to ensure patient safety and to facilitate timely intervention if necessary.

Side Effects

Patients should be aware of the potential adverse reactions associated with the use of this product. Serious reactions may occur, and it is crucial to adhere to the intended use as described on the label. In the event of eye contact, patients are advised to rinse the affected area immediately with water. Should irritation persist, it is important to seek medical assistance promptly.

In addition to the serious warnings, patients may experience irritation to the gums, teeth, or oral mucosa. If such irritation occurs, it is recommended that patients discontinue use of the product and consult their dentist for further evaluation and guidance.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of 2080 K Ginger Mint (sodium fluoride). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 6 years of age should be kept out of reach to prevent accidental ingestion. For this age group, it is recommended to use a pea-sized amount of the product to minimize the risk of swallowing. Caregivers should supervise brushing until proper oral hygiene habits are established. In the event that a child swallows more than the amount intended for brushing, it is crucial to seek professional assistance or contact a Poison Control Center immediately.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

There is no specific information regarding the use of this drug during pregnancy, including safety concerns, dosage modifications, or special precautions. Healthcare professionals should consider the lack of data when prescribing this medication to pregnant patients. It is advisable to weigh the potential benefits against any unknown risks to fetal outcomes. Women of childbearing potential should be counseled on the importance of effective contraception during treatment and the need to inform their healthcare provider if they become pregnant or plan to become pregnant while on this medication.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or lactation considerations. Healthcare professionals should exercise caution when prescribing this medication to lactating mothers, as the effects on breastfed infants are not well characterized. It is advisable to weigh the potential benefits against any unknown risks when considering treatment options for lactating patients.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

There is currently no specific information available regarding overdosage for this medication. Healthcare professionals are advised to monitor patients closely for any signs of adverse effects or symptoms that may arise from excessive dosing.

In the event of suspected overdosage, it is recommended that healthcare providers initiate supportive care and symptomatic treatment as necessary. Patients should be evaluated for potential complications, and appropriate interventions should be implemented based on clinical judgment.

For further guidance, healthcare professionals may refer to established protocols for managing drug overdosage or consult a poison control center.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No specific postmarketing experience details are available. As such, there are no additional adverse events or rare case reports to summarize at this time.

Patient Counseling

Healthcare providers should advise patients to keep this product out of the reach of children under 6 years of age to prevent accidental ingestion or misuse.

Patients should be informed to discontinue use and consult their dentist if they experience any irritation to the gums, teeth, or oral mucosa. It is important for patients to understand the significance of these symptoms and the necessity of seeking professional advice to ensure their oral health is not compromised.

Storage and Handling

The product is supplied in a container that must be kept tightly closed when not in use to maintain its integrity. It should be stored at room temperature, away from direct light to prevent degradation. Once opened, the product should be discarded to ensure safety and efficacy.

Additional Clinical Information

The product is administered via the dental route. Clinicians should advise patients not to swallow the product and to rinse their mouths with water after brushing. For children under 6 years of age, it is recommended to use a pea-sized amount to minimize swallowing, and caregivers should supervise brushing until proper habits are established. If a child swallows more than the amount used for brushing, it is important to seek professional assistance or contact a Poison Control Center immediately.

No additional information is available regarding laboratory tests, abuse potential, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for 2080 K Ginger Mint, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)